Transport activity of human MRP3 expressed in Sf9 cells: Comparative studies with rat MRP3

被引:113
|
作者
Akita, H
Suzuki, H [1 ]
Hirohashi, T
Takikawa, H
Sugiyama, Y
机构
[1] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan
[2] Teikyo Univ, Sch Med, Dept Med, Itabashi Ku, Tokyo 1730003, Japan
关键词
ABC transporter; bile acids; MRP3; organic anion;
D O I
10.1023/A:1013699130991
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. Multidrug resistance-associated protein 3 (MRP3) was initially cloned as a hepatic transporter induced under cholestatic/hyperbilirubinemic conditions. In the present study, transport property of human MRP3 (hMRP3) was compared with that of rat MRP3 (rMRP3). Methods. Adenosine 5' triphosphate (ATP)-dependent uptake of several organic anions into the membrane vesicles isolated from the Sf9 cells expressing hMRP3 and rMRP3 was measured by rapid filtration technique. Results. ATP-dependent uptake of glucuronide conjugates, glutathione conjugates, and [H-3]methotrexate (MTX) was stimulated by infection of cDNAs for hMRP3 and rMRP3. The mean (+/- SE) K-m values for the uptake of 17beta estradiol 17beta-D-glucuronide ([H-3]E(2)17 betaG) by hMRP3 and rMRP3 were 42.9 +/- 4.3 muM and 33.4 +/- 2.2 mum, respectively. Although the K-i values of glucuronides on the uptake of E(2)17betaG were similar in humans and rats, hMRP3 exhibited higher K-i values toward MTX. In addition. although glycocholate and taurolithocholate 3-sulfate (TLC-S) were transported by both hMRP3 and rMRP3, taurocholate was only transported to a significant degree by rMRP3. Moreover, the inhibitory effect of taurocholate and glycocholate on the transport of E(2)17betaG was much more potent in rMRP3 compared to hMRP3. Conclusion. Collectively, the substrate specificity of hMRP3 resembles that of rMRP3 although differences were observed, particularly in bile acid transport.
引用
收藏
页码:34 / 41
页数:8
相关论文
共 50 条
  • [21] Transport of ethinylestradiol glucuronide and ethinylestradiol sulfate by the multidrug resistance proteins MRP1, MRP2, and MRP3
    Chu, XY
    Huskey, SEW
    Braun, MP
    Sarkadi, B
    Evans, DC
    Evers, R
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 309 (01): : 156 - 164
  • [22] MRP3: a molecular target for human glioblastoma multiforme immunotherapy.
    Chien-Tsun Kuan
    Kenji Wakiya
    James E Herndon
    Eric S Lipp
    Charles N Pegram
    Gregory J Riggins
    Ahmed Rasheed
    Scott E Szafranski
    Roger E McLendon
    Carol J Wikstrand
    Darell D Bigner
    BMC Cancer, 10
  • [23] Nuclear receptors RXRα:RARα are repressors for human MRP3 expression
    Chen, Wensheng
    Cai, Shi-Ying
    Xu, Shuhua
    Denson, Lee A.
    Soroka, Carol J.
    Boyer, James L.
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2007, 292 (05): : G1221 - G1227
  • [24] Influence of rifampin and omeprazole on MRP3 expression in human enterocytes and hepatocytes
    Hitzl, M
    Klein, K
    Nüssler, AK
    Neuhaus, P
    Gläser, H
    Drescher, S
    Fritz, P
    Zanger, UM
    Eichelbaum, M
    Fromm, MF
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2002, 365 : R120 - R120
  • [25] Upregulation of basolateral multidrug resistance protein 3 (Mrp3) in cholestatic rat liver
    Donner, MG
    Keppler, D
    JOURNAL OF HEPATOLOGY, 2001, 34 : 88 - 88
  • [26] Expression and localization of the multidrug resistance proteins MRP2 and MRP3 in human gallbladder epithelia
    Rost, D
    König, J
    Weiss, G
    Klar, E
    Stremmel, W
    Keppler, D
    GASTROENTEROLOGY, 2001, 121 (05) : 1203 - 1208
  • [27] Differential modulation of the function of human MRP2 and MRP3 by bile acids and glucuronide conjugates
    Sarkadi, B
    Bodó, A
    Varadi, A
    FASEB JOURNAL, 2003, 17 (04): : A583 - A583
  • [28] Expression and localization of the multidrug resistance proteins MRP2 and MRP3 in human gallbladder epithelia
    Rost, D
    Konig, J
    Weiss, G
    Klar, E
    Stremmel, W
    Keppler, D
    GASTROENTEROLOGY, 2001, 120 (05) : A93 - A93
  • [29] Overexpression of MRP3 in HeLa-UGT1A9 Cells Enhances Glucuronidation Capability of the Cells
    Zhou, Qiong
    Xia, Bijun
    Yin, Taijun
    He, Yu
    Ye, Ling
    Hu, Ming
    CURRENT DRUG METABOLISM, 2021, 22 (10) : 772 - 783
  • [30] Intestinal Breast Cancer Resistance Protein (BCRP)/Bcrp1 and Multidrug Resistance Protein 3 (MRP3)/Mrp3 Are Involved in the Pharmacokinetics of Resveratrol
    van de Wetering, Koen
    Burkon, Alexander
    Feddema, Wouter
    Bot, Alice
    de Jonge, Hugo
    Somoza, Veronika
    Borst, Piet
    MOLECULAR PHARMACOLOGY, 2009, 75 (04) : 876 - 885